Boost your clinical practice with our system of Real World Evidence powered by Artificial Intelligence and is part of a health research network that is based on data, not intuition.
Artificial intelligence to enhance medical evidence
The evolution of health and medicine has been a fascinating journey marked by sacrifices and advancements.
Healthcare professionals, with their absolute dedication, have taught us to care for and value life, both in normalcy and illness. Currently, the speed of technological advancements, especially in the field of medicine, has transformed this evolution into a revolution.
BioSmartData leads this new era, carrying the ancestral tradition into a revolutionary dimension in medicine.
BioSmartData is a cloud software designed and structured on the bases of Real World Evidence that allows the collection of data from real patients related to treatment, communication and from medical equipment, as well as the performance of clinical follow-ups based on objective scales or other follow-up methods.
The system adapts to any clinical treatment, be it a surgical intervention, a medical device or a medicine.
We have a clear commitment to favor data collection in clinical environments, that is why our system allows us to collect all the data associated with clinical treatments in less than 10 minutes .
We seek solutions for all stakeholders in the healthcare ecosystem where the greatest beneficiary will be the patient, who is located at the center of our mission and actions with a higher probability in the best results of their treatments and active participation in their clinical follow-up.
BioSmartData allows the collection of data in regular clinical practice to know the use of products and treatment in real time.
This data can be used by the healthcare industry to improve knowledge of the use of their products, guarantee traceability and post-market monitoring and even develop new clinical applications.
#Post-marketing #On-going Data #Traceability
#Dashboard
The complex algorithm systems that are incorporated into our software not allow us to obtain data on the effectiveness of the treatments, but also to incorporate data on medical expenses to obtain data on efficiency.
This allows health centers to evaluate treatments in a more global way and to improve their profitability.
#RWE #Efficiency #AI #Precision
We provide a software that is easy to use and allows collaboration, data collection and analysis under the control of a high number of variables and the highest level of scientific evidence.
Healthcare professionals will be able to have a greater assurance and security in decision-making with data-driven decisions thanks to the knowledge acquired.
#RWE #AI #On-going Data #Automated tracking #Collaboration #Research
Our software is developed using the latest technology in the technological and digital sector.
All the data is collected taking into account a complete work process, and will later be analyzed to obtain data on product precision, market efficiency, clinical protocol prediction and treatment prescription.
The most important patient data is collected, such as health status, demographic information and general information.
The pathology is identified, the treatment design is carried out and the follow-up scales to be carried out on the patient are selected.
During the treatment process, the data will be collected on critical treatment variables to enable further analysis.
The clinical follow-up is fully digitalised: the scales can be sent automatically to patients and real-time statistics can be generated.
We have clients throughout the national territory Barcelona, Madrid, Coruña, Seville, Córdoba, Málaga, Bilbao, Vitoria, Gran Canaria, Alicante…
Control system that allows the recording of the PRP analysis (number of platelets, leukocytes and erythrocytes), in addition to enabling traceability with the quality control points.
A WAY OF MAKING EUROPE:
TODO Biomedical Consulting Group SL with its PRP Data project within the framework of the ICEX Next Program, has had the support of ICEX and co-financing from the European fund FEDER European Fund for regional development. The purpose of this support is to contribute to the international development of the company and its environment.